Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2019 / Cilt: 53 - Sayı: 4

Chronic Relapsing Inflammatory Optic Neuropathy

Pages
437–440
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The early detection of CRION is important because of the associated risk of blindness if CRION is treated inappropriately.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic relapsing inflammatory optic neuropathy (CRION) is a form of recurrent, isolated, subacute optic neuropathy.
📊
Key Findings & Data:A 33-year-oldfemale presented at an outpatient clinic with a pain-ful reduction of vision in the left eye that had developed 10 days earlier.
💡
Conclusion & Impact:The early detection of CRION is important because of the associated risk of blindness if CRION is treated inappropriately.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Chronic relapsing inflammatory optic neuropathy (CRION) is a form of recurrent, isolated, subacute optic neuropathy. A 33-year-oldfemale presented at an outpatient clinic with a pain-ful reduction of vision in the left eye that had developed 10 days earlier. Thepatient provided a background history of 5 similar attacks over the past 5 years. CRION was diagnosed following ophthalmological and imaging examinations, which revealed optic neuritis without demye-lination. The patient was successfully treated withsteroids. The early detection of CRION is important because of the associated risk of blindness if CRION is treated inappropriately.

🔖

Cite This Article

YASSA, E. T., BAKBAK, B. (2019). Chronic Relapsing Inflammatory Optic Neuropathy. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 53 - Sayı: 4, 437–440. https://ajindex.com/articles/364032

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Rodriguez M, Siva A, Cross SA, O'Brien PC, Kurland LT. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995;45:244–50
  2. Pirko I, Blauwet LA, Lesnick TG, Weinshenker BG. The natural history of recurrent optic neuritis. Arch Neurol 2004;61:1401–5
  3. Kidd D, Burton B, Plant GT, Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain 2003;126:276–84. 4. de Seze J. Inflammatory Optic Neuritis: From Multiple Sclerosis to Neuromyelitis Optica. Neuroophthalmology 2013;37:141–5
  4. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106– 12
  5. Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol 2014;261:17–26
  6. Colpak AI, Kurne AT, Oguz KK, Has AC, Dolgun A, Kansu T. White matter involvement beyond the optic nerves in CRION as assessed by diffusion tensor imaging. Int J Neurosci 2015;125:10–7
  7. Daldal H, Tok OY, Sengeze N, Koyuncuoglu HR, Tok L, Ozkaya D, et al. Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis. Turk J Ophthalmol 2011;41:1–5
  8. Bichuetti DB, de Camargo AS, Falcão AB, Gonçalves FF, Tavares IM, de Oliveira EM. The retinal nerve fiber layer of patients with neuromyelitis optica and chronic relapsing optic neuritis is more severely damaged than patients with multiple sclerosis. J Neuroophthalmol 2013;33:220–4
  9. Stiebel-Kalish H, Hammel N, van Everdingen J, Huna-Baron R, Lee AG. Intravenous immunoglobulin in recurrent-relapsing inflammatory optic neuropathy. Can J Ophthalmol 2010;45:71–5.